- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT03694054
Care Coordination in Oncology, Quality Among Patients With Lung Cancer and Their Caregivers
Exploratory Evaluation of Family Caregiver Application (FCA) on Quality Among Persons With Lung Cancer and Their Family Caregivers
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
The case-matched controlled design, exploratory evaluation study will look at how exposure to a care coordination tool impacts quality and performance indicators associated with oncology care from the perspective of patients, caregivers, and providers.
Geisinger research staff will recruit lung cancer patients and their caregivers across three Geisinger locations: Geisinger Medical Center (GMC), Geisinger Wyoming Valley Medical Center (GWV) and Geisinger Community Medical Center (GCMC). GMC will serve as the intervention site and GWV and GCMC as control sites.
Eligible participants will be identified by the study staff through the electronic health record as well as through clinical staff and approached in the oncology clinic as part of a schedule office visit and/or treatment. For the purpose of study awareness, informational flyers will be available to patients in the exam rooms, waiting rooms, and through Oncology Care's Multi-Disciplinary clinic. Participants will asked to identify a caregiver who will participate in the study as well, however this is not required.
Case dyads enrolled at the intervention site (GMC) will be asked to complete a survey when they join the study and at the end of the study. Participants will also be asked to enroll in the care coordination tool, a health information solution that integrates the patient, caregiver, and clinical data to enhance communication and improve quality of care and performance outcomes. Patients will also be asked to give permission to the study team to access their health information via the e electronic health record. Participants will be in the research study for about 8-10 weeks.
Control dyads enrolled at the control site (GWV and GCMC) will be asked to complete a survey eight weeks after consenting to participate. Patients will be asked to give permission to the study team to access their health information via the electronic health record. Participants will be in the research study for about 8-10 weeks.
The study will also enroll oncology care providers within the Medical Oncology or Radiation Oncology departments at GMC and who have patients enrolled in the study. Providers will be asked to participate in a 30-minute interview to get their feedback and insights on the care coordination tool.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Pennsylvania
-
Danville, Pennsylvania, Vereinigte Staaten, 17822
- Geisinger Health System
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
Patients:
- Patients who are 18 years of age or older and diagnosed with lung cancer who 1) are scheduled to start Oncology Care (chemo and/or radiation-therapies) OR 2) on active Oncology Care and recently started within 3 weeks (<27 days for experimental arm; <56 days control arm)
- Receive care at GMC, GWV, or GCMC
- English-speaking
- Established/intends to establish a MyGeisinger Account (cases only)
Caregivers:
- Recognized/intends to be recognized as proxy for patient's MyGeisinger Account (cases only)
- English-speaking
Providers:
- Any health care provider within Medical Oncology or Radiation Oncology at GMC, where care coordination tool is standard of care, who has a patient enrolled.
Exclusion Criteria:
Patients:
- Patients who are not diagnosed with lung cancer.
- Patients who are diagnosed with lung cancer and are on active Oncology Care exceeding 3 weeks (>27 days experimental arm; >56 days control arm).
Providers:
- Any healthcare provider not within the Medical Oncology or Radiation Oncology departments.
- Any healthcare provider within Medical Oncology or Radiation Oncology who does not have a patient enrolled (Case Dyad).
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Nicht randomisiert
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Care coordination patients, caregivers
Patients and caregivers enroll in using care coordination tool during oncology care and treatment.
|
Participants will be asked to enroll in the care coordination tool, a health information technology solution that integrates cross-sector data to enhance communication and improve quality of care and performance outcomes.
Patients will also be asked to provide consent to allow the study team to access additional health information via the electronic health record.
|
Kein Eingriff: Standard of care patients, caregivers
Patients and caregivers receive oncology care and treatment.
|
|
Experimental: Oncology Care Providers
Oncology care providers with patients enrolled in care coordination tool.
|
Participants will be asked to enroll in the care coordination tool, a health information technology solution that integrates cross-sector data to enhance communication and improve quality of care and performance outcomes.
Patients will also be asked to provide consent to allow the study team to access additional health information via the electronic health record.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Patient Satisfaction
Zeitfenster: 8 weeks
|
To evaluate the difference in patient satisfaction associated with FCA exposure (Case v. Control) will be evaluated using chi-square test, t-tests and non-parametric univariate tests distribution dependent.
Mean patient and caregiver scores will be calculated for each dyad and compared between groups.
Sensitivity analyses may stratify by level of FCA use (low-moderate-high) per dyad and opportunity time for FCA exposure.
Case to Control patient analyses will also be performed to detect role-level differences in perceptions of satisfaction associated with FCA exposure.To evaluate the association of the change in patient satisfaction associated with FCA use difference in response between pre- and post- surveys paired t-test or ANCOVA depending on data type and distribution.
Within Case Dyads, patient means will be compared with caregiver means to detect difference in satisfaction perceptions based on role.
|
8 weeks
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Caregiver Satisfaction
Zeitfenster: 8 weeks
|
To evaluate the difference in caregiver satisfaction associated with FCA exposure (Case v. Control) will be evaluated using chi-square test, t-tests and non-parametric univariate tests distribution dependent.
Mean patient and caregiver scores will be calculated for each dyad and compared between groups.
Sensitivity analyses may stratify by level of FCA use (low-moderate-high) per dyad and opportunity time for FCA exposure.
Case to Control caregiver analyses will also be performed to detect role-level differences in perceptions of satisfaction associated with FCA exposure.
To evaluate the association of the change in caregiver satisfaction associated with FCA use difference in response between pre- and post- surveys paired t-test or ANCOVA depending on data type and distribution.
Within Case Dyads, patient means will be compared with caregiver means to detect difference in satisfaction perceptions based on role.
|
8 weeks
|
Patient Quality of Life
Zeitfenster: 8 weeks
|
To evaluate the difference in patient quality of life associated with FCA exposure (Case v. Control) will be evaluated using chi-square test, t-tests and non-parametric univariate tests distribution dependent.
Mean patient and caregiver scores will be calculated for each dyad and compared between groups.
Sensitivity analyses may stratify by level of FCA use (low-moderate-high) per dyad and opportunity time for FCA exposure.
Case to Control patient analyses will also be performed to detect role-level differences in perceptions of quality of life associated with FCA exposure.To evaluate the association of the change in patient quality of life associated with FCA use difference in response between pre- and post- surveys paired t-test or ANCOVA depending on data type and distribution.
Within Case Dyads, patient means will be compared with caregiver means to detect difference in quality of life perceptions based on role.
|
8 weeks
|
Caregiver Quality of Life
Zeitfenster: 8 weeks
|
To evaluate the difference in caregiver quality of life associated with FCA exposure (Case v. Control) will be evaluated using chi-square test, t-tests and non-parametric univariate tests distribution dependent.
Mean patient and caregiver scores will be calculated for each dyad and compared between groups.
Sensitivity analyses may stratify by level of FCA use (low-moderate-high) per dyad and opportunity time for FCA exposure.
Case to Control caregiver analyses will also be performed to detect role-level differences in perceptions of quality of life associated with FCA exposure.
To evaluate the association of the change in caregiver quality of life associated with FCA use difference in response between pre- and post- surveys paired t-test or ANCOVA depending on data type and distribution.
Within Case Dyads, patient means will be compared with caregiver means to detect difference in quality of life perceptions based on role.
|
8 weeks
|
Family Centered Care
Zeitfenster: 8 weeks
|
To evaluate the difference in family centered care associated with FCA exposure (Case v. Control) will be evaluated using chi-square test, t-tests and non-parametric univariate tests distribution dependent.
Mean patient and caregiver scores will be calculated for each dyad and compared between groups.
Sensitivity analyses may stratify by level of FCA use (low-moderate-high) per dyad and opportunity time for FCA exposure.
Case to Control patient and caregiver analyses will also be performed to detect role-level differences in perceptions of family centered care associated with FCA exposure.
To evaluate the association of the change in family centered care associated with FCA use difference in response between pre- and post- surveys paired t-test or ANCOVA depending on data type and distribution.
Within Case Dyads, patient means will be compared with caregiver means to detect difference in family centered care perceptions based on role.
|
8 weeks
|
Patient Experience
Zeitfenster: 8 weeks
|
To evaluate the difference in patient experience associated with FCA exposure (Case v. Control) will be evaluated using chi-square test, t-tests and non-parametric univariate tests distribution dependent.
Mean patient and caregiver scores will be calculated for each dyad and compared between groups.
Sensitivity analyses may stratify by level of FCA use (low-moderate-high) per dyad and opportunity time for FCA exposure.
Case to Control patient analyses will also be performed to detect role-level differences in perceptions of experience associated with FCA exposure.To evaluate the association of the change in patient experience associated with FCA use difference in response between pre- and post- surveys paired t-test or ANCOVA depending on data type and distribution.
Within Case Dyads, patient means will be compared with caregiver means to detect difference in experience perceptions based on role.
|
8 weeks
|
Caregiver Burden
Zeitfenster: 8 weeks
|
To evaluate the difference in caregiver burden associated with FCA exposure (Case v. Control) will be evaluated using chi-square test, t-tests and non-parametric univariate tests distribution dependent.
Mean caregiver scores will be calculated for each dyad and compared between groups.
Sensitivity analyses may stratify by level of FCA use (low-moderate-high) per dyad and opportunity time for FCA exposure.
Case to Control caregiver analyses will also be performed to detect role-level differences in perceptions of burden associated with FCA exposure.To evaluate the association of the change in caregiver burden associated with FCA use difference in response between pre- and post- surveys paired t-test or ANCOVA depending on data type and distribution.
To evaluate the association of the change in caregiver burden associated with FCA use difference in response between pre- and post- surveys paired t-test or ANCOVA depending on data type and distribution.
|
8 weeks
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Lisa Bailey-Davis, DEd, RD, Geisinger Clinic
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 2018-0172
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Lungenkrebs
-
Hal C CharlesAbgeschlossenKonstriktive Bronchiolitis | Irak-Afganistan War Lung Injury SyndromeVereinigte Staaten
-
Joseph MccuneEunice Kennedy Shriver National Institute of Child Health and Human Development... und andere MitarbeiterBeendetLupus erythematodes, systemisch | Systemische Vaskulitis | Lungenerkrankung mit systemischer Sklerose | Isolierte Angiitis des zentralen Nervensystems | Lung Disease Interstitial DiffusVereinigte Staaten
Klinische Studien zur Care coordination tool
-
VA Office of Research and DevelopmentRekrutierungTotale KnieendoprothetikVereinigte Staaten
-
Assistance Publique - Hôpitaux de ParisUniversity of OxfordAbgeschlossenRandomisierte, kontrollierte StudieVereinigtes Königreich, Frankreich
-
Stanford UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... und andere MitarbeiterAbgeschlossenBurnout, Profi | Resilienz, PsychVereinigte Staaten
-
National University of SingaporeNational Medical Research Council (NMRC), SingaporeAbgeschlossen
-
University of Illinois at ChicagoNational Institute of Nursing Research (NINR)AbgeschlossenErziehung | Fruchtbarkeitsprobleme | OffenlegungVereinigte Staaten
-
Oregon Health and Science UniversityUniversity of Missouri-Columbia; Vanderbilt University Medical CenterRekrutierungHypertonie | Mehrere chronische ErkrankungenVereinigte Staaten
-
The Hospital for Sick ChildrenUniversity Health Network, Toronto; Trillium Health PartnersRekrutierungDiabetes mellitus, Typ 1Kanada
-
Region SkaneRekrutierung
-
Université Paris-SudNoch keine Rekrutierung
-
Centre Hospitalier Universitaire de Saint EtienneLigue contre le cancer, FranceBeendet